Drug Type CAR-T |
Synonyms Anti-CD133 CAR T cell therapy - Century Therapeutics, ECAR 133, ECAR-133 |
Target |
Mechanism CD133 inhibitors(CD133 inhibitors), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | CA | 28 May 2020 |